Location History:
- Higashimurayama-shi, Tokyo, JP (1998)
- Tokyo, JP (1995 - 2000)
- Higashimurayama, JP (1998 - 2001)
Company Filing History:
Years Active: 1995-2001
Title: Michinori Waki: Innovator in Antiviral Research
Introduction
Michinori Waki is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of antiviral research, particularly in the development of novel compounds with potential applications against human immunodeficiency virus (HIV). With a total of seven patents to his name, Waki's work exemplifies innovation in biochemistry and pharmacology.
Latest Patents
Waki's latest patents include groundbreaking inventions such as polypeptide transition metal salts and methods for enhancing the anti-HIV activity of polypeptides. This invention provides a novel salt compound of a polypeptide represented by formula I and a transition metal, which exhibits high antiviral activity against HIV. Another notable patent is a cinnamic acid derivative, which introduces a novel spacer into cinnamic acid that is photodimerizable. This invention also includes a cinnamic acid-polysaccharide derivative that is photocurable with high sensitivity and efficiency, obtainable by introducing the cinnamic acid derivative into a host polysaccharide like glycosaminoglycan. Furthermore, a photocrosslinked cinnamic acid-polysaccharide derivative can be obtained by exposing the same derivative to ultraviolet light irradiation.
Career Highlights
Throughout his career, Michinori Waki has worked with esteemed organizations such as Seikagaku Corporation and Seikagaku Kogyo K.K. His experience in these companies has allowed him to collaborate on various innovative projects, further enhancing his expertise in the field.
Collaborations
Waki has collaborated with notable colleagues, including Akiyoshi Matsumoto and Kenji Miyamoto. These partnerships have contributed to the advancement of his research and the successful development of his patented inventions.
Conclusion
In summary, Michinori Waki is a distinguished inventor whose work in antiviral research has led to significant advancements in the field. His innovative patents and collaborations reflect his commitment to improving health outcomes through scientific discovery.